Journal
JOURNAL OF GASTROINTESTINAL SURGERY
Volume 25, Issue 6, Pages 1380-1387Publisher
SPRINGER
DOI: 10.1007/s11605-020-04688-2
Keywords
Gastric cancer; AJCC; Tumor regression grade; Preoperative therapy; Neoadjuvant therapy; Chemoradiation therapy
Categories
Funding
- US National Institutes of Health [P30 CA016672]
Ask authors/readers for more resources
In gastric cancer patients who underwent preoperative therapy, higher tumor regression grade (TRG) 3 was associated with more advanced ypStage and R1 resection, leading to a shorter overall survival (OS) duration. TRG may be a useful factor for predicting the survival of these patients.
Background TheCancer Staging Manual, 8th edition, now includes post-neoadjuvant therapy (ypTNM) staging for gastric cancer patients. Our purpose was to determine whether the tumor regression grade (TRG) of the primary tumor is useful for predicting the survival of these patients. Methods We performed a retrospective review of an institutional database and identified patients with clinically non-metastatic gastric adenocarcinoma who underwent preoperative chemotherapy or chemoradiation therapy before gastrectomy. Pathology reports were reviewed, and TRG was classified as follows: 0 (complete response), 1 (viable tumor cells <= 1-2%), 2 (viable cells <= 50%), or 3 (viable cells > 50%). Results Of the 356 patients identified, including 80 (23%) with a gastroesophageal junction tumor, 268 (75%) had undergone preoperative chemoradiation therapy. Fifty-six (16%) had TRG 0, 57 (16%) TRG 1, 128 (36%) TRG 2, and 115 (32%) TRG 3. No association between TRG and pretreatment factors was identified, except for signet-ring cell histologic type and tumor location. A higher TRG was associated with more advanced ypT and ypN categories (bothp < 0.001), ypM1 (p = 0.004), and R1 resection (p = 0.052). The median overall survival (OS) duration was 6.6 years, and the 5-year OS rate was 54.1%. TRG 3 was associated with a shorter OS duration than were other TRG scores (p = 0.015), while the OS did not differ significantly among the TRG 0-2 groups (p = 0.803). On multivariable analysis, TRG was not associated with OS after adjustment for ypN status. Conclusion In gastric cancer patients who underwent preoperative therapy, TRG 3 was associated with advanced ypStage and R1 resection. Patients with TRG 3 had a shorter OS duration because of associated advanced ypStage, particularly ypN+ status.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available